FFA
PRQR icon

Farther Finance Advisors’s ProQR Therapeutics PRQR Stock Holding History

Farther Finance Advisors’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86K Hold
1,000
– – ﹤0.01% 5190
2026
Q1 		$1.71K Hold
1,000
– – ﹤0.01% 4948
2025
Q4 		$2.02K Buy
+1,000
New +$2.34K ﹤0.01% 4687

Other funds holding PRQR

FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

Farther Finance Advisors's PRQR Position: Q2 2026 in Review

Farther Finance Advisors held its ProQR Therapeutics (PRQR) position steady in Q2 2026 at 1,000 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #5190.

Farther Finance Advisors first reported a position in PRQR in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.02K in Q4 2025. 3 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • Farther Finance Advisors held 1,000 shares of ProQR Therapeutics worth $1.86K as of Q2 2026.
  • Farther Finance Advisors left its ProQR Therapeutics share count unchanged in Q2 2026.
  • ProQR Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5190 holding.
  • Farther Finance Advisors first reported a position in ProQR Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Farther Finance Advisors's ProQR Therapeutics position peaked at $2.02K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.